Highlighting how technology and mindset shifts can help expand breast cancer research leadership beyond high-income countries ...

Discover the future of schizophrenia research. Join CenExel experts Dr. David Walling and Dr. Lara Shirikjian as they explore ...

Medidata will be expanding its long-standing partnership with Sanofi, now leveraging Medidata Patient, Data, and Study Experiences within the collaboration. The ecosystem of tools aims to address ...

Examining how shifting leadership patterns in breast cancer research signal growing international participation—and the ...

Today’s ACT Brief explores how eConsent is modernizing participant engagement, highlights new data on global representation in breast cancer trials, and examines Moderna’s decision to halt its Phase ...

Revisit top insights from SCOPE Summit 2025, where industry leaders explored how artificial intelligence is reshaping trial ...

At ESMO 2025, AstraZeneca reported that Imfinzi plus BCG therapy reduced the risk of recurrence or death by 32% in patients ...

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical ...

Cross-generational access: Digital technology adoption spans all age groups, with older adults becoming increasingly more comfortable using smartphones and tablets. Features like audio-visual consent, ...

Unlock the advantage of pragmatic trials and improve efficiency and real-world relevance to reduce risk and strengthen ...

In today’s ACT Brief, we revisit key insights from SCOPE Summit 2025 on AI and pragmatic trials, examine Genentech’s Phase III vamikibart data in uveitic macular edema, and highlight MJH Life Sciences ...

At ESMO 2025, Eli Lilly’s Verzenio and Novartis’ Kisqali both demonstrated durable efficacy in hormone receptor-positive, ...